Abstract
Introduction
7 residues and selected hydrophobic residues at various positions. The separation between these 149 groups of Nek kinases based on substrate-specificity is discussed in more detail below. 150
151

Validation of the phosphorylation-site motif for all members of the Nek family 152
To validate our OPLS-results, we designed peptides predicted by our OPLS-results to be 153 good substrates for either the Nek1/3/4/5/8 (13458-tide) group of kinases, or the Nek6/7/9 (679-154 tide) group of kinases. In addition, we synthesized variants of these peptides that contained 155 residues predicted to be disfavored at specified positions ( Fig. 2A) . We tested the phosphorylation 156 of these peptides using in vitro kinase assays with Nek3 and Nek7 as representative members of 157 these Nek kinase groups ( Fig. 2B-D) . As shown in figure 2B and C, Nek3 could readily 158 phosphorylate the optimal Nek13458-tide, but was substantially impaired in its ability to 159 phosphorylate peptides in which either the -3 or -2 hydrophobic residues were mutated to aspartic 160 acid (Fig. 2B, 2C ). As shown in figure 2D , Nek7 phosphorylated the optimal 679-tide much more 161 rapidly than a 679-tide variant containing a disfavored hydrophobic residue (I) in place of the 162 favored hydrophobic residue (L) in the -3 position (Fig. 2D) . Similarly, substitution of the favored 163 aspartic acid residue in the -2 position for a basic residue (R), substantially reduced peptide 164 phosphorylation by Nek7 (Fig. 2D) . 165
Interestingly a subset of Nek kinases, including Nek7, Nek8 and particularly Nek6, displayed 166 unexpected selection for phospho-tyrosine in the -1 position, suggesting that these kinases might 167 target substrates that have been primed by tyrosine kinase mediated phosphorylation. To validate 168 this specificity, we substituted the phospho-tyrosine in the -1 position of 679-tide to an OPLS-169 disfavored isoleucine residue, which resulted in a reduced rate at which Nek6 phosphorylated 170 679-tide (Fig. 2E) . Finally, all of the Nek kinases displayed a strong preference for a tryptophan 171 in the -4 position. Selection for tryptophan within kinase substrate motifs, especially at the -4 172 position, has rarely been observed (Miller et al., 2018) . Corroborating our OPLS-data, the rate at 173 which Nek8 phosphorylated its optimal substrate Nek8-tide was reduced upon substitution of the 174 tryptophan in the -4 position to a valine (Fig. 2F) . Furthermore, introduction of a tryptophan in the 175 -4 position in a peptide that is otherwise a very poor substrate for Nek8 (Nek8-poor) significantly 176 enhanced the rate at which Nek8 could phosphorylate Nek8-poor (Fig. 2F ). Taken together, these 177 results with optimal and suboptimal peptide variants validate our OPLS-data, and demonstrate 178 that we can use the OPLS-data to predict good and poor substrates for the Nek kinases. 179
180
Nek10 is a dual-specificity kinase 181
Curiously, in these OPLS experiments, Nek10 displayed very little sequence preference for 182 any residue, except for a tyrosine at every position (Fig. 3A) . We hypothesized that this result 183 could indicate that Nek10 is a tyrosine kinase. This could explain the effective phosphorylation of 184 all peptide libraries containing a fixed tyrosine, because the tyrosine itself could serve as a 185 phospho-acceptor site. In addition, it would explain the absence of additional preferences, 186 because each of the 198 peptide libraries will contain tyrosine residues on non-fixed positions 187 and therefore have many different target sites (Fig. S1 ). In agreement with this hypothesis, mass 188 spectrometric analysis of in vitro auto-phosphorylated Nek10 revealed the presence of several 189 phosphorylated tyrosine residues (Nasir Haider and Vuk Stambolic, unpublished data). To directly 190 determine if Nek10 phosphorylates tyrosine residues, we designed a Nek10 substrate peptide 191 based on the auto-phosphorylation site data, and introduced either a tyrosine, serine, or threonine 192 at the phospho-acceptor site (Fig. 3B, C) . Surprisingly, Nek10 effectively phosphorylated peptides 193 with a serine phospho-acceptor site, but even more rapidly phosphorylated peptides with a 194 tyrosine phospho-acceptor site (Fig. 3B, C) . In contrast, substitution of threonine as the phospho-195 acceptor significantly impaired peptide phosphorylation by Nek10 (Fig. 3B, C) . We therefore 196 conclude that Nek10 is a tyrosine/serine dual-specificity kinase. 197
None of the other Nek kinases phosphorylated peptides libraries containing tyrosine as the 198 phospho-acceptor (0 position in Fig. 1C, also Fig. S4A ). Therefore, we reasoned that sequence 199 comparison between the Nek kinases might reveal residues that permit Nek10 to phosphorylate 200 both serine and tyrosine residues, since structural analysis has implicated specific regions of the 201 kinase domain that contribute to serine/threonine or tyrosine specificity (Taylor et al., 1995) . One 202 of these regions is the P+1 loop, which lies directly N-terminal of the conserved APE-motif (Fig.  203   3D) . We therefore aligned the P+1 loop sequences of the Nek kinase family members, and noted 204 that Nek10 has an isoleucine whereas all the other Nek kinases have a proline at the position four 205 residues N-terminal of the APE-motif (APE-4; Fig. 3E ). Interestingly, an isoleucine in the APE-4 206 is typically found in tyrosine kinases, but in less than 5% of serine/threonine kinase, which more 207 commonly have a proline on this position (Fig. 3F) . We therefore mutated the APE-4 isoleucine 208 in Nek10 to a proline (I693P), and found that this increased its capacity to phosphorylate a 209 substrate peptide on a serine residue but rendered Nek10 incapable of phosphorylating the same 210 peptide on a tyrosine (Fig. 3G) . 211
Another region contributing to phospho-acceptor site specificity is the catalytic loop, which 212 contains the aspartic acid which serves as the catalytic base within the conserved HRD motif (Fig.  213   3D ; Taylor et al., 1995) . Intriguingly, Nek10 has a threonine in the HRD+2 position, which is 214 uncommon within the serine/threonine kinome. Instead, 86% of serine/threonine kinases contain 215 a lysine residue in the HRD+2 position, including all the other Nek kinases (Fig. 3H, S4B) . 216
Mutation of the HRD+2 threonine to a lysine (T657K) generated a Nek10 variant that, like Nek10 217 I693P, could effectively phosphorylate serine residues but was incapable of phosphorylating 218 tyrosine residues (Fig. 3I) . Finally, we sought to make a variant version of Nek10 that would 219 exclusively phosphorylate substrates on tyrosine residues. To this end, we mutated the threonine 220 in the APE-5 position to a proline, which is highly conserved in tyrosine kinases, but present in 221 only three serine/threonine kinases (Fig. 3F) . In contrast to the I693P and T657K mutations, this 222 APE-5 mutation (T692P) severely reduced overall Nek10 kinase activity (Fig. 3J) . However, the 223 resulting Nek10 T692P variant could still detectably phosphorylate tyrosine residues while it was 224 unable to phosphorylate serine residues (Fig. 3K ). Taken together, these results identify specific 225 residues in the kinase domain of Nek10 that are essential for its dual-specificity, and show that 226 12 do this exclusively (GSK3) or primarily (DYRK) during folding in cis (Cole et al., 2004 ; 278 Soundararajan et al., 2013) . To test whether Nek10 can auto-phosphorylate on tyrosine and 279 serine in trans, we performed in vitro kinase assays using FLAG-tagged WT, serine-specific or 280 tyrosine-specific Nek10 to phosphorylate an HA-tagged KD Nek10 as substrate. Following 281 incubation, Nek10 kinase and substrate were separated by anti-FLAG and anti-HA IP 282 respectively, and analyzed by immunoblotting and phosphorimaging. As shown in figure 5B , 283 phosphorylation of KD Nek10 was observed following incubation with either a serine-specific or 284 tyrosine-specific kinase-proficient Nek10, demonstrating that Nek10 can auto-phosphorylate in 285 trans on both serine and tyrosine residues (Fig. 5B) . 286
Next, to investigate if serine and tyrosine auto-phosphorylation of Nek10 could also occur in 287 cells, we generated Nek10 knock-out U-2 OS cell lines using CRISPR technology (Fig. S5A) . 288
These were then reconstituted with doxycycline-inducible, 3xFLAG-tagged WT, KD, serine-289 specific (I693P(Ser)) and tyrosine-specific (T692P(Tyr)) variants of Nek10 (Fig. 5C ). Tyrosine 290 phosphorylation was assessed by anti-FLAG IP followed by immunoblotting with an antibody 291 recognizing phospho-tyrosine. Clear tyrosine phosphorylation was observed of WT Nek10, but 292 not of a KD or serine-specific variant, consistent with Nek10 auto-phosphorylation on tyrosine 293 residues in cells (Fig. 5D) . In contrast to what we found in vitro however, we could not detect any 294 tyrosine phosphorylation on tyrosine-specific Nek10 (Fig. 5D) , likely due to a combination of the 295 very low activity of this Nek10 variant, and the higher threshold required for antibody detection 296 compared to 32 [P]-radiolabeling. 297
To map the tyrosine(s) targeted for auto-phosphorylation by Nek10, we used the OPLS 298 phosphorylation-site motif to select seven candidate Nek10 target sites, and mutated each of 299 these sites to a phenylalanine. WT and mutant kinases containing 3xFLAG-tags were expressed 300 in U-2 OS cells, followed by anti-FLAG IP and immunoblotting for phospho-tyrosine. As shown in 301 figure 5E, tyrosine-phosphorylation was detected in each of the mutants, but the signal was 302 substantially reduced upon mutation of Y644, suggesting that Y644 is a major auto-303 13 phosphorylation target site of Nek10 (Fig. 5E ). An in vitro kinase assay using tyrosine-specific 304
Nek10 and a KD Nek10 substrate with or without the Y644F mutation, confirmed that Nek10 305 directly auto-phosphorylates Y644 in trans (Fig. 5F ). Interestingly, the Y644F mutation 306 dramatically reduced the activity of Nek10 in an in vitro kinase assay with a serine peptide 307 substrate (Fig. 5G) , and a similar result was obtained with a tyrosine peptide substrate (Fig. S5B) . 308
These results strongly indicate that Nek10 auto-phosphorylation on Y644 contributes to its 309
activity. 310
Finally, to study serine auto-phosphorylation in cells, we isolated WT, KD, serine-specific and 311 tyrosine-specific Nek10 from the doxycycline-induced Nek10 knock-out cells (Fig. 5C ), and 312 analyzed its phosphorylation status by mass spectrometry. Multiple phosphopeptides were 313 detected, but the region corresponding to N346-R365 of Nek10, which is outside of the kinase 314 domain, was the most abundant phosphopeptide in the WT and serine-specific samples, and was 315 completely absent in the KD and tyrosine-specific samples (Fig. S5C, S5D ). This peptide contains 316 six serine residues, of which four were identified as phosphorylated by MASCOT protein 317 identification software (Fig. S5C) . Mutation of these four serine sites in KD Nek10 reduced its 318 phosphorylation by a serine-specific Nek10 variant, demonstrating that one or more of these sites 319 can be auto-phosphorylated in trans by Nek10 (Fig. 5H) . To determine which of these four sites 320 was the most likely target site, we manually annotated the MS/MS spectra, and identified S358 of 321 Nek10 as the phosphosite most consistent with the mass spectrometry data (Fig. S5E) . Therefore, 322
we conclude from these results that Nek10 can auto-phosphorylate in trans, both in vitro and in 323 cells, and identified Y644 in the kinase domain, and S358 outside of the kinase domain, as auto-324 phosphorylation target sites. 325
326
The Nek kinase family diverges into four specificity-groups 327
The OPLS results indicated that there are substantial differences in specificity among the 328 14 clustering of the Nek kinome based on quantitative OPLS motif information. To also include Nek10 330 in this analysis, we used the serine phosphorylation-site OPLS motif (Nek10(S)), because the 331 tyrosine phosphorylation-site motif is very distinct from the motifs of the other Nek kinases. This 332 clustering revealed that Nek1/3/4/5/8 were clearly separated from Nek2/6/7/9/10(S) (Fig. 6A) . 333
Importantly, this division of the Nek kinases based on preferred substrate sequence cannot be 334 explained by amino acid sequence similarity between the Nek kinase domains themselves (Fig.  335   6B) . Instead, an important contributor to this hierarchy is the preference for either serine or 336 threonine as the phospho-acceptor site (Fig. 6C) . To assess non-phosphosite contributions, we 337 re-clustered the Nek kinase family based on motif specificity, but excluded the phospho-acceptor 338 site preference (Fig. 6D ). This revealed that within the group of threonine-directed Nek kinases, 339
Nek 1/3/4 cluster separately from Nek 5/8 (Fig. 6D ). Overall then, the motif data indicate that the 340
Nek kinase family can be separated into four specificity groups based on phospho-acceptor 341 preference and additional amino acids specificities (Fig. 6D) . Interpretation of the sequence logos 342 shown in Fig. 1C indicates that Nek 1, 3 and 4 cluster in Group 1 based on their shared preference 343 for arginine in the -1 position. Within Group 1, Nek 1 and 4 also show strong selectivity for lysine 344 and arginine in the +2 position, and they are exceptional in their lack of preference for a tryptophan 345 in the -3 position. Group 2 consists of Nek 5 and 8, and is closely related to Group 1, but has a 346 less prominent selection for arginine in the -1 position. Group 3, which consists of Nek 2 and 10, 347 are distinguished by their serine phospho-acceptor specificity (Fig. 6C, S4A ), although the 348 remaining motif specificity of Nek 2 is similar to that of kinases in Group 2 (Fig. S3) . Finally, Group 349 4 consists of Nek6, 7, and 9, and clusters distantly from the rest (Fig. 6D ) based on a preference 350 for acidic residues in the -5, -4, and particularly in the -2 position that is not shared with any of the 351 other Nek kinases (Fig. 6E) . 352
To rationalize the unusual selectivity for acidic residues displayed by Group 4 Nek kinases, 353
we compared the X-ray crystal structures of the Nek1 and Nek7 kinase domains (Haq et al., 2015; 354 Melo-Hanchuk et al., 2017) . This revealed the presence of two basic regions in Nek7 that are 355 absent from Nek1, and might accommodate acidic residues N-terminal of the phospho-acceptor 356 site (Fig. 6F) . Additional crystal structures of these kinases with substrate peptides will be 357 necessary to experimentally validate these observations. To further investigate the relevance of 358 these motif differences between Group 4 and the other Nek kinases in substrate phosphorylation, 359
we then performed in vitro kinase assays using Nek3 and Nek7 with either a good peptide-360 substrate for Groups 1 and 2 (13458-tide), or a good peptide-substrate for Group 4 (679-tide). As 361 predicted, 13458-tide was a considerably better substrate for Nek3 than 679-tide, and this was 362 reversed for Nek7 (Fig. 6G) . 363 364 Nek6/7/9 share a common substrate motif with Polo-like Kinase 1 and can phosphorylate 365 the same substrates 366
We noticed a striking resemblance between the Nek6/7/9 motif, and the phosphorylation-367 site motif previously obtained for Plk1 ( Fig. 7A ; Alexander et al., 2011). Hierarchical clustering of 368 the Nek-family and Plk1 based on substrate motif data from OPLS revealed that, with regards to 369 substrate specificity, Nek6/7/9 are more related to Plk1 than they are to the other Nek kinases 370 (Fig. 7B ). Importantly Plk1, together with Cdk1, has previously been reported as the upstream 371 activator of Nek6/7/9 (Bertran et al., 2011). Hence, Plk1 and Nek6/7/9 not only operate together 372 in a linear signaling cascade during mitosis, but also share the same phosphorylation-site motif, 373 and hence could potentially phosphorylate a common set of substrates. 374
To assess potential substrate overlap, we used the quantitative specificity information derived 375 from the OPLS experiments to predict substrates for Plk1 and Nek6/7/9 using the Scansite scoring 376 algorithm (Obenauer et al., 2003) . We restricted the scoring to sites that are present in the 377
Phophositeplus database of previously reported phosphorylation sites in the human proteome, to 378 exclude sites that are potentially not surface-accessible (Hornbeck et al., 2015) . We considered 379 the top 10% of best scoring sites as potential targets. This analysis revealed a substantial overlap 380 in candidate substrates among the different kinases: over 50% of Plk1 target sites were also 381 predicted to be a good target site for at least one of the Nek kinases, and a total of 2801 sites 382 were predicted to be good target sites for all four kinases (Fig. 7C) . 383
Next, we considered the possibility that substrates previously assigned as direct Plk1 targets 384 on the basis of inhibitor or knockdown studies might actually be either direct substrates of 385 Nek6/7/9, or are shared direct substrates of both Plk1 and Nek6/7/9. To address this possibility, 386
we analyzed the candidate Plk1 substrates at the mitotic spindle that were obtained in a 387 phosphoproteomic study, during which either a small molecule inhibitor or an shRNA was used 388 to block Plk1 function (Santamaria et al., 2011) . Scansite scoring of these substrates showed a 389 strong correlation between the Nek7-scores and Plk1-scores (Fig. 7D) . Using a cut-off for the top 390 25% of best-scoring sites, we identified 109 distinct sites on 77 different proteins as potential 391 targets of both Plk1 and Nek7. This included S453 on Cdc27, and S170 on RacGAP1, both of 392 To test whether Nek7 could also directly phosphorylate these substrates, we generated WT 394
Cdc27 and S434A/S435A double mutant proteins using in vitro transcription/translation (IVTT), 395 and incubated them with isolated Plk1 or Nek7 in an in vitro kinase assay. As previously reported, 396
Cdc27 was readily phosphorylated by WT but not KD Plk1, and this phosphorylation was reduced 397 by mutation of the S434/S435 target site (Fig. 7E , upper panels; Kraft et al., 2003) . Interestingly, 398 the same assay performed with Nek7 instead of Plk1 demonstrated that Nek7 could also 399 phosphorylate Cdc27 on the same site as Plk1 (Fig. 7E, lower panels) . A second in vitro kinase 400 assay using RacGAP1 confirmed that this substrate is also directly phosphorylated by both Plk1 401 and Nek7, although both kinases appear to target sites other than or in addition to S170 (Fig. 7G) . 402
Together, these experiments indicate that Plk1 and Nek6/7/9 share a strikingly similar (Fig. 6C) . 420
Overall, the phosphorylation-site motifs indicate that the Nek family can be divided in four 421 specificity-groups (Fig. 6D, 7A ). To date, all kinases in specificity Groups 3 (Nek2/10) and 4 422 (Nek6/7/9) have been implicated in one or more mitotic processes, with the exception of Nek10. 423
The exact function of Nek10 is not known, but it has previously been reported to play a role in the 424 response to UV-stress (Moniz and Stambolic, 2011 (Table S1 ) reveals an overrepresentation of 449 leucine and phenylalanine in the -3 position, consistent with the motif reported here. Of the eleven 450 published Nek6 substrates, three contain an asparagine on the -2 position, which we identified as 451 a specificity unique to Group 4 Nek kinases, and four others have a glycine, which is also 452 positively selected for by Nek6. It is important to emphasize that substrate phosphorylation by a 453 kinase does not require a perfect match between the target site and the optimal motif. Rather, the 454 better the site matches the optimal motif, the more efficiently it is phosphorylated by the kinase 455 (Obenauer et al., 2003) , as we also demonstrate here in our peptide phosphorylation studies (Fig.  456 
2B-F). 457
Importantly, our assays revealed that Nek10 is a dual-specificity kinase, and thus joins a 458 small group of human serine/threonine kinases with reported dual-specificity. These are the GSK-459 3 kinases, the DYRK-kinases, the kinases of the MAP2K-family, TTK, CK2, Myt1 and the TESK-460 therefore an exception within the group of dual-specificity kinases, because they can efficiently 470 phosphorylate multiple protein substrates in trans on both tyrosine and serine (Toshima et al., 471 1999) . 472
Here, we show that Nek10's dual-specificity is most like that of the TESK-kinases, because 473 Nek10 phosphorylates tyrosine residues as efficiently as serine residue on substrates in trans. 474
Serine/threonine kinases are structurally different than tyrosine kinases, primarily in the catalytic 475 loop and the P+1 loop of the kinase domain. These regions make extensive contact with the 476 substrate, including with the phospho-acceptor site, and structural differences within these loops 477 dictate whether kinases exclusively phosphorylate either serine/threonine or tyrosine (Taylor et 478 al., 1995) . We show here that an isoleucine in the APE-4 position, and a threonine in the HRD+2 479 position, makes the P+1 loop and catalytic loop of Nek10 unlike those typically found in either 480 tyrosine kinases or serine/threonine kinases, and these unique residues give Nek10 the capacity 481 20 to phosphorylate substrates on tyrosine in addition to serine. Serine/threonine kinases have a 482 conserved lysine on the HRD+2 position in the catalytic loop, which makes contact with the P+1 483 loop and the substrate backbone, and therefore helps positioning the substrate for 484 phosphorylation. The HRD+2 threonine, rather than lysine, in Nek10 is essential for its ability to 485 phosphorylate substrates on tyrosine, and within the dual-specificity kinome this residue is only 486 shared with the TESK kinases. This could potentially explain why of all dual-specificity kinases, 487
Nek10 and the TESK kinases appear to have the broadest tyrosine phosphorylation capacity. The 488 serine/threonine kinases BubR1, Plk4, PRPK and MISR2 also have a serine or threonine residue 489 in the HRD+2 position, suggesting that they might be dual-specificity. Notably, murine Nek1 has 490 been reported to be a dual-specificity kinase (Letwin et al., 1992), but we could not detect any 491 tyrosine-phosphorylation by human Nek1 (Fig. S4A) , and Nek1 has neither the HRD+2 threonine, 492 nor the APE-4 isoleucine that distinguishes Nek10 from the other Nek family members (Figs. 3E, 493
H). 494
Additionally, the sequence surrounding the phosphorylation site also affects substrate 495 positioning, and can therefore affect phospho-acceptor site specificity. As an example of this 496 interdependence, we have previously noted that the preference of the kinases ATM/ATR for 497 phosphorylating serine-glutamine versus threonine-glutamine motifs appears to depend on the 498 residues found at other positions in the motif (Joughin et al., 2012) . A similar observation of 499 interdependence between phospho-acceptor residue identity and specific amino acids in other 500 positions within the motif has been shown for the dual-specificity kinase CK2 (Marin et al., 1999) . 501
Marin et al observed that tyrosine phosphorylation of a yeast substrate of CK2 depended on 502 specific residues in the -1 and +1 positions. However, phosphorylation of the same substrate with 503 the tyrosine replaced by a serine residue was considerably less influenced by substitutions of the 504 amino acids in the -1 and +1 positions and instead depended on the residue identity in the +3 505 position (Marin et al., 1999) . Here, we identified distinct phosphorylation-site motifs for Nek10 on 506 tyrosine and on serine/threonine substrates (Fig. 4) . This indicated that the ability of Nek10 to 507 phosphorylate peptides on tyrosine was strongly dependent on the presence of an aromatic 508 residue or a leucine in the +1 position of the substrate (Fig. 4C ), but Nek10 was much more 509 tolerant of other amino acids in this position when phosphorylating substrates on serine (Fig. 4A) . 510
Potentially, a bulky +1 residue orients the substrate within the catalytic cleft in a manner that 511 generates space for the large tyrosine phospho-acceptor site. 512
Finally, our study showed that Nek6/7/9 share a common phosphorylation motif with Plk1. 513
Plk1 interacts with Nek9 and functions as the upstream activating kinase in a linear mitotic 514 signaling pathway with Nek6, 7, and 9, raising the possibility that the common phosphorylation 515 motif we observed arises from cross-contamination in the isolated kinase preparations. However, 516 the fact that our Plk1 motif was determined using the recombinant kinase domain of Plk1 517 expressed in bacteria, and that catalytically dead versions of each of these Nek kinases displayed 518 no phosphorylation activity ( Fig. S2 ) argues against this interpretation. Instead, it may be that 519 these mitotic kinases function together to form a coherent feed-forward loop analogous in some 520 ways to the coherent type 1-feed forward loop with OR gate function described by Uri Alon for 521 transcription factor signaling (Alon, 2007). Such a signaling network of kinases sharing a highly 522 related phosphorylation-site motif (Fig. 7G ) might allow persistence of this phospho-motif for a 523 period of time after Plk1 inactivation, or could help spread this specific phospho-motif beyond 524 direct Plk1 substrates by acting as a "phospho-motif amplifier". Clearly, many future experiments 525 investigating the spatial and temporal phosphorylation of in vivo substrates by kinases within this 526 network will be required to distinguish between these and other possibilities. 527 528 22
Materials and methods
530
Cloning 531
Coding DNA sequences of Nek1 and Nek3-Nek9 were obtained from the human ORFeome 532 collection. Using gateway cloning technology, Nek3-Nek9 were cloned into V1900, a gateway 533 destination vector derived from pCMV-Sp6 with a C-terminal 3xFLAG epitope tag 534 (DYKDHDGDYKDHDIDYKDDDDK). All other cloning was done by restriction ligation, Quick-535
Fusion cloning (Biotool.com) or Gibson assembly using the NEBuilder HiFi DNA assembly 536
Cloning Kit (New England Biolabs). Nek1 was PCR-amplified from the ORFeome entry vector, 537
and cloned into pcDNA3 that was re-engineered to contain a C-terminal 3xFLAG tag (pcDNA3-538 MCS-3xFLAG). The Nek4 kinase domain (aa: 1-300) was PCR amplified from the V1900-Nek4 539 plasmid, and cloned into pcDNA3-MCS-3xFLAG. The Nek5 kinase domain (aa: 2-300) was PCR 540 amplified from the V1900-Nek5 plasmid, and cloned into pcDNA3, which was reengineered with 541 an N-terminal MBP (maltose-binding-protein)-3xFLAG epitope tag. The Nek2 kinase domain (aa: 542 1-271) was PCR amplified from copy-DNA generated from U-2 OS mRNA, and cloned into 543 pcDNA3, which was reengineered with a C-terminal 3xFLAG-TEV-2xStreptagII-6xHIS epitope 544 tag. (TEV: Tobacco Etch Virus cleavage site (ENLYFQG), StreptagII: WSHPQFEK). The 545 construct pCMV-3xFLAG-Nek10 has been described previously (Moniz and Stambolic, 2011). A 546 small missing region in the Nek10 cDNA (bp: 2869-3012) was repaired by PCR, and the cDNA 547 including N-terminal 3xFLAG-tag was subcloned into pcDNA3, or the cDNA without 3xFLAG-tag 548 was subcloned into pcDNA3-2xHA-Strep, which is a pcDNA3-variant that was re-engineered for 549 epitope-tagging with an N-terminal 2xHA-StreptagII epitope tag (HA: YPYDVPDYA). The Plk1 550 kinase domain (aa: 38-346) was PCR-amplified from plasmids previously described and cloned 551 into pET-RSF (Elia et al., 2003) . Cdc27 and RacGAP1 cDNA was PCR amplified from copy-DNA, 552
and cloned into pcDNA3-2xHA-Strep. All mutants of the Neks, and Cdc27 and RacGAP1 mutants, 553 were generated by PCR-mediated mutagenesis. All kinase-dead variants were made by mutation 554 of the aspartic acid in the conserved HRD motif into an asparagine, and in case of Nek4, an 555 additional aspartic acid to asparagine mutation was made in the conserved DFG-motif (DLG in 556 case of Nek4). In order to make the Nek10 KO cell-line, a Nek10-targeting sgRNA (sequence: 557 GTCTGAGCCCGCCATCAGGG) was cloned into lentiGuide-Puro (addgene #52963), and Cas9 558 was subcloned from pCW-Cas9 (addgene #50661) into pLVX-Cas9-ZsGreen. In addition, a Cas9-559 targeting sgRNA (sequence: CTTGTACTCGTCGGTGATCA) was cloned into lentiguide-puro. 560
The inducible Nek10 construct was generated by replacing Cas9 in pCW-Cas9 with 3xFLAG-561 Nek10-T2A-eGFP. Silent mutations were introduced in the PAM-sequence of the Nek10 sgRNA 562 target site, and the puromycin cassette in pCW was replaced with a blastidicin resistance 563
cassette. 564 565
Protein production and purification 566
All Nek kinases, unless indicated otherwise below, were purified from transiently transfected HEK 567 293T cells. In short, 7x10
6 HEK 293T cells were plated in 15 cm plates, and the next day 568 transfected with 20-25 µg kinase-DNA using polyethyleneimine (PEI). After O/N incubation, 569 transfection medium was replaced with fresh medium, and another 24h later cells were washed 570 with PBS and harvested by scraping in lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM 571 EDTA, 1 mM EGTA, 1% Triton-X100, 1 mM DTT) supplemented with protease inhibitors 572 (cOmplete EDTA-free protease inhibitor cocktail, Roche) and phosphatase inhibitors (PhosSTOP, 573 Roche). Lysates were incubated on ice for 20 minutes, and cleared by centrifugation. Next, anti-574 FLAG M2 affinity gel (Sigma) was added to the cleared lysate, followed by incubation for 2h at 575 4°C while rotating. After incubation, the beads were pelleted by centrifugation, washed twice with 576 lysis buffer and washed twice again with wash buffer (50 mM HEPES pH 7.4, 100 mM NaCl, 1 577 mM DTT, 0.01% NP-40, 10% glycerol). Protein was eluted from the beads by incubation for 1h at 578 RT (while rotating) with 150-250 µl wash buffer supplemented with phosphatase inhibitors 579 (PhosSTOP, Roche) and 0.5 mg/ml 3xFLAG peptide (APExBIO). To determine concentration and 580 purity, a BSA standard curve and a sample of the eluate were analyzed by SDS-PAGE and 581
Coomassie-staining (SimplyBlue Safe stain, Life Technologies). Eluted kinase was either used 582 directly, or snap-frozen and stored at -80°C. The 2xHA-Streptag-Nek10 KD (HA-tagged Nek10 583 KD, fig. 5 ) was isolated essentially exactly as described above. However, Strep-Tactin XT 584 superflow (IBA lifesciences) was used instead of anti-FLAG affinity gel, the composition of the 585 wash buffer was different (100 mM Tris pH 8, 150 mM NaCL, 1 mM EDTA) and the kinase was 586 eluted in 1x Biotin elution buffer BXT (IBA lifesciences). Plk1 was isolated from bacteria. A BL21 587
Rosetta 2 strain was transformed and induced to express the 6xHIS-MBP-TEV-tagged Plk1 588 kinase domain. The bacteria were lysed, followed by incubation with an Amylose resin (New 589 England Biolabs)) and elution with maltose. In case of constitutively active T210D Plk1, a second 590 purification step on a nickel-column (Ni Sepharose 6 Fast Flow, GE Healthcare) was performed, 591 followed by imidazole-elution. 
Biotin)-NH2, were X= mixture of all natural amino acids except Cys, Ser and Thr, S/T=equal 599 mixture of Ser and Thr, and LC-Biotin= long chain biotin. In each peptide pool, the Z is fixed to be 600 a single amino acid, which can be any of the 20 natural amino acids or phospho-Thr or phospho-601
Tyr. In the example, the Z is positioned on the P-5 relative to the S/T, but in the complete library 602 the Z would be fixed in a position ranging from -5 to +4 relative to the S/T. Hence, there are nine 603 different positions and 22 different amino acids, generating 198 different peptide pools. In 604 addition, the library contains three peptide pools that are completely degenerate with the 605 exception of a fixed Ser, Thr or Tyr as phospho-acceptor site for use in determining the 0 position 606 (Fig. S1) . The tyrosine-peptide library (custom order, JPT) consisted of peptide pools with the 607
, and in this library Cys, Ser, Thr 608 and Tyr were absent from the amino acid mixtures on the X positions. All peptides were dissolved 609 in DMSO to 7.5 mM for the Ser/Thr library, and 5mM for the Tyr-library. The peptides were arrayed 610 in a 1536-well plate by multi-channel pipetting, and diluted to 500 µM with water. 611
For the kinase assay, 2.2 µl kinase buffer per well was dispensed in 1536-well plates using 612 a Mantis nanodispenser robot (Formulatrix). The core kinase buffer consisted of 50 mM Tris-HCl 613 pH 7.5, 0.1 mM EGTA, 1 mM DTT, 50 µM ATP, 1 mM PKA-inhibitor (Sigma) and 0.1% Tween-614 20, and was supplemented with 10 mM MgCl2 and 2mM MnCl2 for Nek1/2/3/4/6/7/9, 10 mM 615
MnCl2 for Nek5/8, and 10 mM MgCl1 and 10 mM MnCl2 for Nek10. Next, 250 nl peptide was 616 transferred from the peptide-stock plate to the kinase assay plate using a pintool with slot tips 617 briefly to collect all liquid, and cooled on ice as needed to prevent evaporation. After addition of 621 the kinase, the plate was incubated at 30°C for 2h. Subsequently, 250 nl of each reaction was 622 spotted on streptavidin-membrane (Promega) using the pintool, the membrane was washed and 623 dried, exposed to a phosphorimaging screen, and imaged on a Typhoon 9400 imager (GE 624
Healthcare). 625
Spot intensities were quantified using ImageStudio (Li-COR BioSciences), and normalized 626 by dividing the measured intensity for an individual spot by the average spot intensity for all amino 627 acids in that position. For each kinase, OPLS-experiments were done at least twice, and 628 26 normalized values were averaged for all replicates. In case of a fixed serine or threonine on the 629 Z-position, the fixed residue presents a second acceptor site in addition to the 0-position S/T, and 630 spot intensities are therefore high at those positions, which does not necessarily reflect real 631 sequence preferences. To correct for this, normalized intensities for fixed S or T were changed to 632 1 in case of intensity>1. For Nek10 on the Tyr-library, the same was done but for intensities 633 measured for fixed-Tyr peptides. The exception was the +1 Tyr, because we reasoned the 634 normalized intensity>1 most likely reflected a true preference, considering its strong preference 635 for aromatic amino acids. Next, normalized values were log2-transformed. These values were 636 used to generate heatmaps using Morpheus (https://software.broadinstitute.org/ morpheus/). 637
These values were transformed to sequence logos with Seq2Logo (Thomsen et al., 2012) . 638 639
In vitro kinase assays 640
For in vitro kinase assays with a peptide-substrate, 5-50 nM of kinase was pre-incubated at 30°C 641 for 30 minutes in the same kinase buffer as used for OPLS, but without the 0.1% Tween-20. 642
Subsequently, [g- respectively. After spotting, the phosphocellulose papers were immediately soaked in 0.5% 654 phosphoric acid. At the end of the assay, all papers were washed three times in 0.5% phosphoric 655 acid, air-dried, transferred to vials with scintillation counter fluid and counted by a LS 6500 656 scintillation counter (Beckman Coulter). The resulting data points were analyzed by linear 657 regression, and the phosphorylation rate was defined as the slope of the linear regression curve. 658
To study Nek10 auto-phosphorylation, 250 ng kinase was incubated in OPLS-kinase buffer 659 with 1 µCi/µl [g-32 P]-ATP for 30 minutes at 30°C. The reaction was stopped by adding 6x sample 660 buffer (SB) for SDS-PAGE (208 mM Tris-HCl pH 6.8, 42% glycerol, 3 mM beta-mercapto-ethanol, 661 10% SDS, 5 mg/ml bromophenol blue) and boiling for 5 minutes at 95°C. The sample was split, 662
and analyzed by SDS-PAGE followed by Coomassie staining to asses total Nek10 levels, or 663
analyzed by SDS-PAGE followed by phosphorimaging to analyze protein phosphorylation. 664
To study Nek10 auto-phosphorylation in trans, 250 ng of FLAG-tagged kinase-proficient 665 in kinase buffer. The mixture was incubated at 30°C for 15 min to 2h, depending on the assay, 667 and the reaction was stopped by adding lysis buffer supplemented with EDTA to a final 668 concentration of 20 mM. The sample was split in half and incubated for 1h at RT (while rotating) 669 with either anti-FLAG M2 affinity gel (Sigma) or anti-HA affinity matrix (mAb 3F10; Roche). The 670 beads were washed once with lysis buffer, dried, and resuspended in 1xSB. Nek10 was eluted of 671 the beads by boiling in 1xSB, the sample was split, and 1/4th was analyzed by SDS-PAGE 672 followed by immunoblotting to asses total Nek10 levels, while 3/4 th was analyzed by SDS-PAGE 673 followed by phosphorimaging to assess protein phosphorylation. 674 675
U-2 OS KO cell-line generation 676
All cell-lines were grown at 37°C in a humidified incubator supplied with 5% CO2, in DMEM 677 supplemented with 10% FBS. Lentivirus was produced by transient transfection of HEK 293T 678 28 cells using the CalPhos mammalian transfection kit (Clontech laboratories) to introduce packaging 679 vectors (VSVg and GAG/POL/D8.2) and either pLVX-Cas9-Zsgreen, or lentiguide-PURO-Nek10 680 sgRNA, or pCW-Nek10-T2A-GFP-Blasticidin. The viral supernatant was filtered through a 0.45 681 µm filter and used to transduce U-2 OS target cells. First, U-2 OS cells were transduced with 682 Cas9, followed by sorting for Zsgreen positive cells. These cells were then transduced with Nek10 683 sgRNA, followed by selection with puromycin (2 µg/ml; Invivogen). Doubly-transduced cells were 684 subsequently cultured for two weeks to allow editing, and single cell sorted into 96-well plates. 685
After expansion of the single-cell clones, gene editing was analyzed by PCR-amplifying the edited 686 locus from gDNA, followed by Sanger sequencing of the PCR product. 687
After selecting a Nek10-KO clone, Cas9 was removed by transfecting with a Cas9-sgRNA 688 construct using lipofectamine 2000 (Thermo Fisher Scientific). Cells were cultured for ten days 689 and sorted for ZsGreen-negative cells. Immunoblot analysis indicated that although all cells were 690 negative for Zsgreen, about 30% of Cas9-expression still remained. Next, the cells were 691 transduced with the pCW-Nek10 constructs, followed by selection with Blasticidin S (10 µg/ml; 692 Invitrogen). To select for cells without leaky expression of Nek10, but good induction upon 693 treatment with doxycycline, the following was done: first, GFP-negative cells were sorted, followed 694 by induction of Nek10 expression with 2 µg/ml doxycycline (Sigma) for several days, and a second 695 round of sorting, this time on GFP-positive cells. 696 697
Antibodies and western blotting 698
Cell lysates was analyzed by SDS-PAGE, and transferred to nitrocellulose membranes by tank 699 electrotransfer. Membranes were blocked using either 5% skim milk in Tris-Buffered-Saline 700 After primary antibody incubation, the membranes were washed 3x with TBS-T, followed by 707 staining with secondary antibody in Odyssey blocking buffer for 1h at RT. Secondary antibodies 708 used were Goat-anti-Mouse, Goat-anti-Rabbit, or Goat-anti-Rat, all from LI-COR, all 1:10,000, 709 and all labeled with either IRDye 680 or IRDye 800. After secondary antibody staining, the 710 membranes were washed again 3x with TBS-T, and imaged with an Odyssey CLx scanner (LI-711 COR BioSciences). Image analysis was done using ImageStudio (LI-COR BioSciences). 712
713
Nek10 auto-phosphorylation in cells 714
To study phosphorylation in cells, U-2 OS cells were transfected with the 3xFLAG-Nek10 vector 715 using lipofectamine 2000 (Thermo Fisher Scientific) for transient expression, or 3xFLAG-Nek10 716 expression was induced in the stable U-2 OS Nek10 KO cell lines with inducible Nek10 by 717 treatment with docxycycline for 48h. The cells were lysed and Nek10 was immobilized on anti-718 FLAG beads as described in the "protein purification'" section above. Next, beads were washed 719 three times with lysis buffer, and all bound proteins eluted by boiling in 1xSB. To study tyrosine 720 phosphorylation, eluates and total cell lysates were analyzed by SDS-PAGE followed by 721 immunoblotting. To analyze serine phosphorylation by mass spectrometry, eluates were 722 separated by SDS-PAGE, followed by Coomassie staining of the gel. The band containing 723 3xFLAG-Nek10 was excised, reduced and alkylated, followed by in-gel trypsin digestion. Tryptic 724 peptides were extracted, desalted and lyophilized. Next, phosphopeptides were enriched using 725 the High-Select Fe-NTA phosphopeptide enrichment kit (ThermoFisher Scientific) per 726 manufacturer's instructions. The elution tubes were coated with trypsinized BSA to prevent loss 727 of phospho-peptides from binding to the tube wall. Eluted phosphopeptides were re-suspended 728 in 0.1% acetic acid and separated by reverse phase HPLC using an EASY-nLC1000 (Thermo) 729 with a self-pack 5 µm tip analytical column (12 cm of 5 µm C18, New Objective). Next, peptides 730 were ionized by nanoelectrospray and analyzed using a QExactive HF-X mass spectrometer 731 (ThermoFisher Scientific). The full MS-scan was followed by MS/MS for the top 15 precursor ions 732 in each cycle. Raw mass spectral data files (.raw
Motif analysis and substrate prediction 739
The hierarchical clustering based on the OPLS-datasets was done using the averaged, 740 Figure 1 Nek6/7/9 Nek6/7
Statistical analysis
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-5 -4-3 -2-1 0 +1+2+3+4 Position relative to APE The phosphorylation rate was determined by linear regression (Mean ± SEM, n=3, ****P<0.00005). (C) As in panel (A), but now for WT Nek10, and using a peptide library with a fixed tyrosine as the phosphoacceptor site (n=3). Note that in this case the 0 position column contains no peptide libraries. (norm. intensity)
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Fig.5 Nek10 autophosphorylates on both tyrosine and serine residues (A) Purified wild-type (WT), kinase-dead (KD), serine-specific (I693P(Ser)), or tyrosine-specific (T692P(Tyr)) Nek10 was incubated in vitro with radiolabeled ATP. Total Nek10 levels were analyzed by coomassie-staining, while phosphorylated (P) Nek10 was detected by phosphorimaging.
32 P dark and 32 P light respectively indicate a longer and shorter exposure of the same gel. (B) In vitro kinase assay with indicated FLAG-tagged Nek10 variants as the kinase, and HA-tagged Nek10 KD as the substrate. Kinase-proficient and kinase-dead Nek10 were separated by anti-FLAG and anti-HA IP respectively, and analyzed by immunoblotting and phosphorimaging. (C) Nek10 KO U-2 OS cells were reconstituted with doxycycline (Doxy) inducible FLAG-Nek10 variants and treated with 2 µg/ml doxycycline for 7 days, or left untreated. FLAG-Nek10 levels were analyzed by immunoblotting. (D) Cells described in panel (C) were treated with doxycycline for 2 days, and FLAG-Nek10 was isolated by α-FLAG IP, followed by immunoblotting to detect total Nek10 (α-FLAG) and tyrosine-phosphorylated Nek10 (α-pY) (TCL=total cell lysate). (E) U-2 OS cells were transfected with an empty vector control (EV) or the indicated FLAG-Nek10 variants. For WT and KD Nek10, less plasmid was transfected than for the Nek10 Y-to-F mutants. FLAG-Nek10 was isolated by α-FLAG IP and analyzed by immunoblotting. (F) As in panel (B), now using FLAG-tagged Nek10, either KD or tyrosine-specific (T692P(Tyr)), as the kinase, and HA-tagged Nek10 KD, either lacking additional mutations or with a Y644F mutation, as the substrate. (G) Purified Nek10 WT or the Y644F mutant was incubated with a peptide substrate and radiolabeled ATP. Peptide phosphorylation was quantified by scintillation counting. The phosphorylation rate was determined by linear regression (Mean ± SEM, n=3, ***P<0.0005). Note that the autophosphorylation-defective Y644F mutant has dramatically reduced activity. (H) As in panel (B), now using FLAG-tagged Nek10, either KD or serine-specific (I693P(Ser)), as the kinase, and HA-tagged Nek10 KD, either lacking additional mutations or with a S353A/S356A/S358A/S359A quadruple mutation (SSSS/AAAA), as the substrate.. 
Clustering based on specificity: No S vs T -1.5 , were scored for their match to the Plk1 or Nek7 phosphorylation-site motif using the Scansite algorithm. Note the lower the score, the better the phosphorylation site sequence matches the optimal motif, with a score of 0 indicating a perfect match. Dotted lines indicate the 25% cut-off for best scoring sites. (E) Purified wild-type (WT) or kinase-dead (KD) Plk1 or Nek7 was incubated with HA-tagged Cdc27 WT or S434A/ S435A double mutant (SS/AA), followed by phosphorimaging ( 32 P) and immunoblotting for kinase and Cdc27 substrate levels. (F) As in panel (E), now using RacGAP1 WT or S170A mutant as substrate. (G) A model of the signaling interactions and common phosphorylation site motif shared between Plk1, Nek9, Nek6, Nek7 that result in potential phospho-motif amplification during mitosis. Supplementary figure 1. Experimental lay-out of an OPLS-experiment. Experimental lay-out of an OPLS-experiment. Biotinylated peptide libraries are incubated in vitro with an isolated kinase and radiolabeled ATP, in independent reactions in a multiwell plate. The peptide libraries are then transferred to a streptavidin membrane, and the level of phosphorylation quantified by measuring the intensity of radiolabel incorporation using a phosphorimager. The example shows a basophilic kinase with a preference for basic residues on the -2 and -3 positions, a preference for a serine as the phospho-acceptor site, and a strong selection against a proline in the +1 position..
-2 -1 0 +1 +2 +3 +4 Z = fixed amino acid X = Mix of all amino acids (no C, S, or T)
2. Array in multiwell plate 1a. Design 198 peptide libraries...
3. Add kinase and [γ-33 ]-ATP Analyze phoshorylation of peptide 1b. ... and design three phospho-acceptor peptide libraries
-5 -4 -3 -2 -1 0 +1 +2 +3 +4
Nek8 KD Ser) ), tyrosine-specific (T692P(Tyr)) or kinase-dead (KD) was isolated from the cells described in figure 5C and analyzed by mass spectrometry. Table shows Table S1 Table S1 List of sites phosphorylated by the Nek kinases. The Phosphositeplus database was mined for sites on human substrates that have been reported to be phosphorylated by any of the Nek kinases for which we determined the motif in this manuscript. The -3 column is shaded yellow. Leucine, methionine and phenylalanine are colored in purple in the -3 and +1 positions for all Nek kinases, asparigine is colored in red in the -2 position for Nek6, and basic residues are colored in blue in the -1 and +2 positions for Nek1 and Nek3.
Supplementary Figure 2
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